Similar articles

• The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?

  van Hooff MH. van Hooff MH. J Assist Reprod Genet. 1995 Apr;12(4):233-5. doi: 10.1007/BF02212923. J Assist Reprod Genet. 1995. PMID: 7580017 Review. No abstract available.
• The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo replacement.

  Vargyas JM, Morente C, Shangold G, Marrs RP. Vargyas JM, et al. Fertil Steril. 1984 Nov;42(5):745-9. Fertil Steril. 1984. PMID: 6436069
• The combined use of human menopausal gonadotropin and Parlodel (bromocriptine) for in vitro fertilization.

  Margalioth EJ, Navot D, Rabinowitz R, Laufer N, Lewin A, Schenker JG. Margalioth EJ, et al. Int J Fertil. 1986 Sep-Oct;31(4):278, 282-3. Int J Fertil. 1986. PMID: 2878897
• Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.

  Gong F, Tang Y, Zhang H, Lu G. Gong F, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;34(3):185-9. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19349670
• [Ovarian stimulation in an in-vitro fertilization programme].

  Diedrich K, Hasani S, van der Ven H, Lehmann F, Krebs D. Diedrich K, et al. Geburtshilfe Frauenheilkd. 1983 Aug;43(8):486-9. doi: 10.1055/s-2008-1036561. Geburtshilfe Frauenheilkd. 1983. PMID: 6413292 German.